FDA Approves Tylenol Nonprescription Fixed-Dose Combination of Acetaminophen and Naproxen Sodium for 12-Hour Pain Relief
On Jul. 24, 2026, U.S. Food and Drug Administration (FDA) approved Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium…
-
-
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for Treatment of ADHD
On Jul. 24, 2026, Otsuka Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted approval…
-
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
On Jul. 20, 2026, Bristol Myers Squibb announced it will expand its compute infrastructure to deploy an NVIDIA…
-
Samsung Biologics announces all-cash offer to acquire PolyPeptide for CHF 1.46 billion, expanding global network across U.S., Europe, and India
On Jul. 19, 2026, Samsung Biologics announced the launch of an all-cash public tender offer to acquire 100%…
-
Agriculture | Biotechnology | Environmental | EPA | FDA | Forestry | Genomics | Implants | Infectious Disease | Marine Science | Medical Device | Oncology | Organ Transplant | Organoids | Pharmaceutical | Quantum | Robotics | Software | Stem Cell | U.S. Congress | Vaccine | Veterinary | Women's Health
New PhD Admissions Data Show Threat to U.S. STEM Workforce, Breakthroughs and Innovations
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
-
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
On Jul. 7, 2026, Vertex Pharmaceuticals and Crinetics Pharmaceuticals, a global pharmaceutical company focused on the discovery, development…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic debuts AI-driven pharma R&D tool, Claude Science
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
-
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera for $1 Billion
On Jun. 17, 2026, Biogen and RayThera, a private biotechnology company focused on discovering and developing small molecule…
-
Protillion Biosciences Signs Drug Discovery Collaboration with Merck Worth $510 Million
On Jun. 16, 2026, Protillion Biosciences, a leader in lab-in-the-loop AI drug design,announced the signing of a multi-target…
-
GSK enters agreement to acquire Nuvalent for $10.6 Billion
On Jun. 9, 2026, GSK announced that it has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage…
-
Artificial Intelligence | Biotechnology | Clinical Research | Genomics | Pharmaceutical | Therapeutics
Google DeepMind, Google.org and Sanger Institute to launch new AI consortium for genomics
On Jun. 8, 2026, the Wellcome Sanger Institute, Google.org, and Google DeepMind announced they are partnering up to…
-
Johnson & Johnson to Acquire Firefly Bio for $1 Billion in Cash to Expand Oncology Pipeline
On Jun. 8, 2026, Johnson & Johnson announced it has entered into a definitive agreement to acquire Firefly…
-
Roche announces global collaboration with Nurix Therapeutics worth up to $2.3 billion
On Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with…
-
Lilly announces three acquisitions to build infectious disease portfolio for $3.8 Billion in Cash
On May 26, 2026, Eli Lilly announced agreements to acquire three companies, Curevo, LimmaTech Biologics, and Vaccine Company,…
-
Scientists solve 200-year-old puzzle of how tobacco plants make nicotine
On May 18, 2026, scientists from the University of York and University of Copenhagen announced they have uncovered…
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion USD
On May 7, 2026, Angelini Pharma and Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and…
-
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility
On May 6, 2026, Eli Lilly announced an additional $4.5 billion investment across two of its three Lebanon…
-
UCB to acquire Candid Therapeutics for more Than $2 Bllion, building upon its existing immunology pipeline
On May 3, 2026, UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it…
-
Purdue Pharma sentenced in connection with its 2020 Plea Agreement with U.S. Department of Justice
On Apr. 28, 2026, the U.S. District Court for the District of New Jersey sentenced Purdue Pharma in…
-
Sun Pharma, India’s Largest drug Firm to Buy U.S., to Acquire Organon for $11.75 Billion
On Apr. 27, 2026, Sun Pharmaceutical Industries and Organon announced they have entered into an agreement under which…
-
Amazon Bio Discovery Launches lab-in-the-loop drug discovery
On Apr. 14, 2026, Amazon announces launching AI BioDiscovery Contract Research Orgainzation. Lab-in-the-loop drug discovery has transformed research…
-
Biotechnology | Diagnostics | Genomics | Infectious Disease | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Trump administration drops court fight to cap NIH payments for research overhead costs
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
Life Science Industry’s Rapid Growth in Washington State Challenged by NIH Budget Cuts
On Apr. 7, 2026, LifeScienceHistory.com, formerly WashingtonLifeScience.com, announces release of a report highlighting the challenges of Washington State’s…
-
Artificial Intelligence | Biotechnology | Cloning | CRISPR | Diagnostics | Genomics | Implants | Infectious Disease | Life Science History | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Pharmaceutical | Quantum | Therapeutics | U.S. Congress
China Tops U.S. in R&D Spending
On Mar. 31, 2026, the Organisation for Economic Co-operation and Development (OECD), reports that China has officially crept…
-
Biogen to Acquire Apellis for $5.6 billion, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
Lilly to acquire Centessa Pharma to advance treatments for sleep-wake disorders in deal worth up to $7.8 Billion
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
-
Artificial Intelligence | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | Pharmaceutical | Therapeutics
China biotech deals hit record as innovative drugs draw interest of multinationals
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
-
Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly
On Mar. 29, 2026, generative-AI drug developer Insilico Medicine announced that it has agreed to a global licensing…
-
Biotechnology | Disease | FDA | Pharmaceutical | Rare Disease | Stem Cell
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
-
Biotechnology | Disease | Neurology | Oncology | Pharmaceutical | Quantum
Merck to Acquire Terns Pharmaceuticals for $5.7 Billion, Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
